The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population
2011

Study of a Genetic Mutation Linked to Immune Deficiency in Moroccans

Sample size: 10 publication Evidence: high

Author Information

Author(s): Naamane H, Ailal F, Abidi O, Jeddane L, Najib J, Barakat A, Bousfiha AA

Primary Institution: Institut Pasteur, Casablanca, Morocco

Hypothesis

The study aims to describe the immunological and molecular characteristics of Moroccan patients with MHC class II deficiency.

Conclusion

The study found a common genetic mutation in Moroccan patients that is linked to a deficiency in immune response.

Supporting Evidence

  • Patients showed a lack of MHC class II molecules on their immune cells.
  • All patients had the same homozygous mutation in the RFXANK gene.
  • The findings suggest a founder effect for the mutation in the North African population.

Takeaway

Some people in Morocco have a gene problem that makes it hard for their bodies to fight off sickness, and scientists found the same mistake in all of them.

Methodology

Immunological examinations and molecular analysis were conducted on ten unrelated Moroccan patients.

Participant Demographics

Ten unrelated Moroccan patients with MHC class II deficiency.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication